BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26871568)

  • 1. Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.
    Beaulieu YB; Leon Machado JA; Ethier S; Gaudreau L; Steimle V
    PLoS One; 2016; 11(2):e0148753. PubMed ID: 26871568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression.
    Bhat KP; Truax AD; Brooks JK; Greer SF
    Immunol Cell Biol; 2010; 88(8):807-16. PubMed ID: 20351748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.
    Schnappauf F; Hake SB; Camacho Carvajal MM; Bontron S; Lisowska-Grospierre B; Steimle V
    Eur J Immunol; 2003 Aug; 33(8):2337-47. PubMed ID: 12884309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
    Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
    Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.
    Masternak K; Reith W
    EMBO J; 2002 Mar; 21(6):1379-88. PubMed ID: 11889043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation and ubiquitination of degron proximal residues are essential for class II transactivator (CIITA) transactivation and major histocompatibility class II expression.
    Bhat KP; Truax AD; Greer SF
    J Biol Chem; 2010 Aug; 285(34):25893-903. PubMed ID: 20538595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression.
    Zika E; Fauquier L; Vandel L; Ting JP
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16321-6. PubMed ID: 16254053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The class II transactivator requires brahma-related gene 1 to activate transcription of major histocompatibility complex class II genes.
    Mudhasani R; Fontes JD
    Mol Cell Biol; 2002 Jul; 22(14):5019-26. PubMed ID: 12077331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple interactions between BRG1 and MHC class II promoter binding proteins.
    Mudhasani R; Fontes JD
    Mol Immunol; 2005 Apr; 42(6):673-82. PubMed ID: 15781111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity.
    Nickerson K; Sisk TJ; Inohara N; Yee CS; Kennell J; Cho MC; Yannie PJ; Nunez G; Chang CH
    J Biol Chem; 2001 Jun; 276(22):19089-93. PubMed ID: 11279191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human MHC class II gene transcription directed by the carboxyl terminus of CIITA, one of the defective genes in type II MHC combined immune deficiency.
    Zhou H; Glimcher LH
    Immunity; 1995 May; 2(5):545-53. PubMed ID: 7749985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5'-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes.
    van der Stoep N; Quinten E; van den Elsen PJ
    J Immunol; 2002 Nov; 169(9):5061-71. PubMed ID: 12391222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CIITA promoter I CARD-deficient mice express functional MHC class II genes in myeloid and lymphoid compartments.
    Zinzow-Kramer WM; Long AB; Youngblood BA; Rosenthal KM; Butler R; Mohammed AU; Skountzou I; Ahmed R; Evavold BD; Boss JM
    Genes Immun; 2012 Jun; 13(4):299-310. PubMed ID: 22218223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-association of CIITA and its transactivation potential.
    Sisk TJ; Roys S; Chang CH
    Mol Cell Biol; 2001 Aug; 21(15):4919-28. PubMed ID: 11438649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen and major histocompatibility class II expression in mesenchymal cells from CIITA hypomorphic mice.
    Xu Y; McDonald J; Perloff E; Butticè G; Schreiber BM; Smith BD
    Mol Immunol; 2007 Mar; 44(7):1709-21. PubMed ID: 16982097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex.
    Masternak K; Muhlethaler-Mottet A; Villard J; Zufferey M; Steimle V; Reith W
    Genes Dev; 2000 May; 14(9):1156-66. PubMed ID: 10809673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250.
    Raval A; Howcroft TK; Weissman JD; Kirshner S; Zhu XS; Yokoyama K; Ting J; Singer DS
    Mol Cell; 2001 Jan; 7(1):105-15. PubMed ID: 11172716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes.
    Kanazawa S; Peterlin BM
    Int Immunol; 2001 Jul; 13(7):951-8. PubMed ID: 11431425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.